Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | MEN1 | O00255 | 4/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | BRD4 | O60885 | 1/20 | 0.52 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | MB | P02144 | 1/20 | 0.52 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.52 |
| ▸ | CA3 | P07451 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | RARG | P13631 | 1/20 | 0.52 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13598484 | 0.85 | SMN1; SMN2 (0.57) | SMN1; SMN2HTTL3MBTL1TSHRKMT2A | |
| SCHEMBL6285087 | 0.84 | RXFP1 (0.54) | SMN1; SMN2L3MBTL1TSHRALDH1A1MAPT | |
| SCHEMBL27808997 | 0.83 | SMN1; SMN2 (0.55) | SMN1; SMN2HTTL3MBTL1TSHRKMT2A | |
| SCHEMBL11134234 | 0.83 | TGM2 (0.43) | SMN1; SMN2TSHRKMT2AALDH1A1MEN1 | |
| SCHEMBL16092931 | 0.81 | SMN1; SMN2 (0.53) | SMN1; SMN2HTTL3MBTL1TSHRKMT2A | |
| SCHEMBL28268244 | 0.81 | SMN1; SMN2 (0.53) | SMN1; SMN2HTTL3MBTL1TSHRKMT2A | |
| SCHEMBL6279031 | 0.81 | TGM2 (0.59) | HSD17B10LMNACYP1A2 | |
| SCHEMBL7754428 | 0.81 | PEPD (0.52) | SMN1; SMN2TSHRKMT2AALDH1A1MEN1 | |
| SCHEMBL11774737 | 0.81 | CYP1A2 (0.41) | SMN1; SMN2TSHRKMT2AALDH1A1MEN1 | |
| SCHEMBL839533 | 0.80 | SMN1; SMN2 (0.61) | SMN1; SMN2HTTL3MBTL1TSHRKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140243547-A1 | LINEAR (PER) FLUOROPOLYETHERS WITH -CF(CF3)COF END GROUPS AND DERIVATIVES THEREOF | SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) | 2014-08-28 | — | — | US | disclosed |
| WO-2013050273-A1 | LINEAR (PER)FLUOROPOLYETHERS WITH -CF(CF3)COF END GROUPS AND DERIVATIVES THEREOF | SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) | 2013-04-11 | — | — | WO | disclosed |
| US-8278256-B2 | Fluorinated lubricants | SOLVAY SOLEXIS S.P.A. (IT) | 2012-10-02 | — | — | US | disclosed |
| US-8217119-B2 | Additives for halopolymers | SOLVAY SOLEXIS S.P.A. (IT) | 2012-07-10 | — | — | US | disclosed |
| US-20100069275-A1 | Fluorinated lubricants | SOLVAY SOLEXIS S.P.A. (IT) | 2010-03-18 | — | — | US | disclosed |
| US-20090326154-A1 | Additives for Halopolymers | SOLVAY SOLEXIS S.P.A. (IT) | 2009-12-31 | — | — | US | disclosed |
| US-7629483-B2 | Peroxidic perfluoropolyethers | SOLVAY SOLEXIS S.P.A. (IT) | 2009-12-08 | — | — | US | disclosed |
| US-20080194881-A1 | Copolymers having functional end groups of sulfonyl fluorides and acyl fluorides; macromer promoters useful for both condensation and addition polymerizations for elastomers and polymershaving a crystal structure; mechanical properties; lubricants for magnetic disks; adhesives | SOLVAY SOLEXIS S.P.A. (IT) | 2008-08-14 | — | — | US | disclosed |
| US-7371900-B2 | Peroxidic perfluoropolyethers | SOLVAY SOLEXIS S.P.A. (IT) | 2008-05-13 | — | — | US | disclosed |
| US-7365229-B2 | Peroxidic perfluoropolyethers | SOLVAY SOLEXIS S.P.A. (IT) | 2008-04-29 | — | — | US | disclosed |
| US-6232430-B1 | PYRROLIDIN-2,5-DIONE COMPOUND | JDS UNIPHASE PHOTONICS C.V. (NL) | 2001-05-15 | — | — | US | disclosed |
| EP-0934266-A1 | CROSS-LINKERS FOR CROSS-LINKABLE OPTICAL POLYCARBONATES | Akzo Nobel N.V. (NL) | 1999-08-11 | — | — | EP | disclosed |
| WO-1998017644-A1 | CROSS-LINKERS FOR CROSS-LINKABLE OPTICAL POLYCARBONATES | AKZO NOBEL N.V. (NL) | 1998-04-30 | — | — | WO | disclosed |
| US-5171676-A | Hydroxylation with Beauveria sulfurescens, while preserving peroxide linkage; antimalarial agents | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1992-12-15 | — | — | US | disclosed |
| US-4173544-A | SOLVENT- AND OXYGEN-FREE CONDENSATION OF AN ALKYL-ANILINE AND -BENALDEHYDE | BBC BROWN BOVERI & COMPANY LIMITED (CH) | 1979-11-06 | — | — | US | disclosed |
| US-4060491-A | 5-ALKYL BENZOTRIAZOLE | MOBIL OIL CORPORATION (US) | 1977-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140243547-A1 | LINEAR (PER) FLUOROPOLYETHERS WITH -CF(CF3)COF END GROUPS AND DERIVATIVES THEREOF | COXFA4, CYP4F3, ETFB | SMN1; SMN2 2771/4885HTT 2320/4885L3MBTL1 4386/4885 |
| US-20080194881-A1 | Copolymers having functional end groups of sulfonyl fluorides and acyl fluorides; macromer promoters useful for both condensation and addition polymerizations for elastomers and polymershaving a crystal structure; mechanical properties; lubricants for magnetic disks; adhesives | FOXO1, FOXM1, F12 | SMN1; SMN2 513/4885HTT 2792/4885L3MBTL1 2259/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.